Fiorinal is a Schedule III controlled substance under federal law. It contains butalbital, a barbiturate, combined with 325 mg of aspirin and 40 mg of caffeine. The butalbital component (50 mg per capsule) is what triggers the controlled classification, as barbiturates carry a recognized potential for dependence and misuse.
Why Fiorinal Is Schedule III
The DEA classifies butalbital as a Schedule III controlled substance, meaning it has a moderate-to-low potential for physical and psychological dependence. Aspirin and caffeine are not controlled on their own, but because Fiorinal contains butalbital and is not on the DEA’s list of exempted prescription products, the entire formulation falls under Schedule III restrictions.
This distinction matters because a closely related medication, Fioricet, swaps aspirin for acetaminophen and has been granted an exemption from scheduling at the federal level. That means Fioricet is not a federally controlled substance in most situations, even though it contains the same 50 mg of butalbital. The difference comes down to how the DEA evaluates the overall formulation, not just the individual ingredients. If your doctor switches you from one to the other, the pharmacy rules change significantly.
How Schedule III Affects Your Prescription
Because Fiorinal is Schedule III, it comes with tighter prescribing and refill rules than a standard prescription medication. Federal regulations allow a maximum of five refills on a single Fiorinal prescription, and the entire prescription expires six months after the date it was written. After that, your doctor must write a new one. Partial fills are permitted, but the total amount dispensed across all partial fills cannot exceed the original quantity prescribed, and no dispensing can occur past the six-month window.
Your pharmacist is also required to keep more detailed records for Schedule III drugs. In practice, this means refill requests may take slightly longer to process, and you cannot transfer the prescription between pharmacies as freely as you could with a non-controlled medication.
State Laws Can Be Stricter
At least 15 states impose Schedule III controls on butalbital products that the federal government has otherwise exempted. Alabama, Alaska, California, Georgia, Hawaii, Idaho, Illinois, Indiana, Kentucky, Maryland, Mississippi, New Mexico, Oklahoma, Pennsylvania, and Utah all treat these products as Schedule III regardless of federal exemption status. If you live in one of these states, even Fioricet may be handled as a controlled substance at the pharmacy. For Fiorinal, which is already Schedule III federally, state rules generally align with or exceed federal requirements.
The Barbiturate Component and Dependence Risk
Butalbital is a barbiturate, a class of drugs that slows activity in the central nervous system. It produces a sedating, muscle-relaxing effect that helps relieve tension headaches. But barbiturates also carry a real risk of physical dependence when used regularly or in large doses. Over time, your body adjusts to the drug’s presence, and stopping suddenly can trigger withdrawal symptoms.
For people who take Fiorinal for headaches, the first sign of withdrawal is often a new headache, sometimes called a rebound or medication-overuse headache. This creates a cycle where the drug that was treating your headaches starts causing them, prompting you to take more. This is one of the main reasons doctors tend to limit how often Fiorinal is used and for how long.
Butalbital also amplifies the effects of alcohol and other sedating medications. Combining Fiorinal with alcohol, sleep aids, or anti-anxiety drugs increases the risk of excessive sedation and slowed breathing. This interaction is not minor and applies even at normal doses of each substance.
What Fiorinal Is Prescribed For
Fiorinal is primarily used to treat tension-type headaches. Each of its three ingredients plays a role: butalbital relaxes muscle tension and reduces anxiety, aspirin addresses pain and inflammation, and caffeine enhances the pain-relieving effects of the other two while also helping to constrict blood vessels in the head. It is not typically a first-line treatment for headaches. Most doctors reserve it for cases where over-the-counter options have not worked, and they generally prescribe it for short-term or intermittent use rather than daily prevention.
A version of Fiorinal with codeine also exists, which pushes it into an even more tightly controlled category because codeine is an opioid. If your prescription includes codeine, the restrictions on refills and record-keeping are more stringent.

